Similarly, enzalutamide stimulated transcription of NR3C1 and SLC7A11 but not PSA or TMPRSS2 (Supplementary Figure S3D and E), suggesting that enzalutamide-stimulated transcription is not limited to a single prostate cancer cell line. Here, NR3C1 is linked to prostate carcinoma.